Search

everythinglearnresearchcommunity

for

Search:↓

The new test can measure very small amounts of testosterone in hair, and grinding the hair up first gives more accurate results.

Zinc supplements may be needed to treat hair loss in hypothyroidism.

MTX and GC combinations are the most effective for early rheumatoid arthritis.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

Some drugs can cause skin, nail, and hair problems, which are important for healthcare professionals to recognize and report.

Vitiligo is linked to autoimmune diseases and hearing issues, so hearing tests are recommended for patients.

Some drugs can cause hair loss, change hair color and shape, or increase hair growth, and treatment may involve stopping the drug or using specific hair growth treatments.

Early onset and pustules indicate severe hair follicle inflammation, and while antibiotics help, the condition often worsens after treatment stops.

The document concludes that alopecia areata is an autoimmune disease without a definitive cure, but treatments like corticosteroids are commonly used.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

Some drugs can cause hair loss, excessive growth, or color changes, often reversible but sometimes permanent.

Female pattern hair loss involves hormonal factors, genetics, and may be linked to low ferritin levels.

People with alopecia areata often have higher rates of allergies and autoimmune diseases.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Low vitamin D receptor levels found in hair loss patients; topical vitamin D treatment suggested.

The document suggests that there might be an autoimmune link between polycystic ovary syndrome and Graves' disease.

The document concludes that diagnosing and treating hair loss is complex and requires understanding its psychological effects and underlying causes, while also calling for more research and new treatments.

Higher DKK-1 levels found in hair loss patients; L-ascorbic acid 2-phosphate, L-threonate, and ginsenoside F2 may help promote hair growth.

The document concludes that changes in eyelashes and eyelid skin can indicate various local and systemic diseases.

Pediatricians should treat some hair loss types in children and refer others to a dermatologist.

Hair loss has many causes and treatments, and losing some hair daily is normal; proper diagnosis is key, and minoxidil can help treat it.

Mild thyroid issues don't affect the metabolism and hormones of women with PCOS.

Most vitiligo patients in Makkah are young women, often with family history and thyroid issues.

A woman's hair loss was probably caused by the antifungal drug anidulafungin.

Platelet-Rich Plasma (PRP), a protein-rich extract from a patient's blood, shows promise in improving hair density, thickness, and quality, but the best method of use and number of treatments needed for noticeable results are still unclear.

Targeting glycolysis may help treat PCOS by improving insulin sensitivity and ovarian function.

Two patients developed complete hair loss after Alemtuzumab treatment for MS, with no regrowth after two years.

A woman lost her hair after taking acyclovir, but it grew back when she stopped the medication.